ATE426170T1 - Prognostischer allergie- oder entzundungstest - Google Patents

Prognostischer allergie- oder entzundungstest

Info

Publication number
ATE426170T1
ATE426170T1 AT99903464T AT99903464T ATE426170T1 AT E426170 T1 ATE426170 T1 AT E426170T1 AT 99903464 T AT99903464 T AT 99903464T AT 99903464 T AT99903464 T AT 99903464T AT E426170 T1 ATE426170 T1 AT E426170T1
Authority
AT
Austria
Prior art keywords
antibodies
antigen
child
allergy
peptides
Prior art date
Application number
AT99903464T
Other languages
English (en)
Inventor
Hugh Sampson
Original Assignee
Allertein Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allertein Therapeutics Llc filed Critical Allertein Therapeutics Llc
Application granted granted Critical
Publication of ATE426170T1 publication Critical patent/ATE426170T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/02Nutritional disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
AT99903464T 1998-01-30 1999-01-28 Prognostischer allergie- oder entzundungstest ATE426170T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7317198P 1998-01-30 1998-01-30
PCT/US1999/001832 WO1999039211A1 (en) 1998-01-30 1999-01-28 Prognostic allergy or inflammation test

Publications (1)

Publication Number Publication Date
ATE426170T1 true ATE426170T1 (de) 2009-04-15

Family

ID=22112157

Family Applications (2)

Application Number Title Priority Date Filing Date
AT99903464T ATE426170T1 (de) 1998-01-30 1999-01-28 Prognostischer allergie- oder entzundungstest
AT08005972T ATE550665T1 (de) 1998-01-30 1999-01-28 Test zur vorhersage von allergien

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT08005972T ATE550665T1 (de) 1998-01-30 1999-01-28 Test zur vorhersage von allergien

Country Status (10)

Country Link
US (1) US6238925B1 (de)
EP (2) EP1051626B1 (de)
JP (1) JP4292262B2 (de)
AT (2) ATE426170T1 (de)
AU (1) AU741635B2 (de)
CA (1) CA2319317C (de)
DE (1) DE69919327D1 (de)
ES (2) ES2229673T3 (de)
HK (2) HK1032262A1 (de)
WO (1) WO1999039211A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10110838C2 (de) * 2001-03-06 2003-04-03 Mlu Halle Wittenberg Verfahren zur Diagnostik von Allergien, Pseudoallergien und Intoleranzen
WO2002073209A2 (de) * 2001-03-10 2002-09-19 Affina Immuntechnik Gmbh Verfahren zur identifikation von immunreaktiven epitopen auf proteinen
NZ542866A (en) 2003-04-23 2009-07-31 Medarex Inc Compositions and methods for the therapy of inflammatory bowel disease
CN102863532A (zh) 2004-06-21 2013-01-09 米德列斯公司 干扰素α受体1抗体及其用途
US8859210B2 (en) * 2008-10-17 2014-10-14 Mead Johnson Nutrition Company Method for identifying allergenic proteins and peptides
CN102341705B (zh) * 2009-03-05 2015-08-19 味之素株式会社 克罗恩氏病诊断试剂
WO2011032097A1 (en) * 2009-09-14 2011-03-17 Mount Sinai School Of Medicine Methods for characterizing antibody binding affinity and epitope diversity in food allergy
WO2012135313A1 (en) * 2011-03-28 2012-10-04 University Of Massachusetts Compositions and methods for detecting allergy to a-gal epitopes
WO2013163176A1 (en) 2012-04-23 2013-10-31 Allertein Therapeutics, Llc Nanoparticles for treatment of allergy
EP3760223A1 (de) 2013-04-03 2021-01-06 N-Fold Llc Neuartige nanopartikelzusammensetzungen
KR102202575B1 (ko) 2013-12-31 2021-01-13 삼성전자주식회사 메모리 관리 방법 및 장치
WO2015153151A1 (en) * 2014-04-03 2015-10-08 Genisphere, Llc Peptides, reagents and methods for detecting food allergy
CN107110855A (zh) 2014-11-14 2017-08-29 拜尔梅里科有限公司 Ibs 敏感度测试的组合物、设备以及方法
EP3173789A1 (de) * 2015-11-24 2017-05-31 Helmholtz-Zentrum für Infektionsforschung GmbH Verfahren zur differenzierung einer immunantwort in einem individuum
CN116183928A (zh) * 2016-04-26 2023-05-30 拜尔梅里科有限公司 溃疡性结肠炎敏感测试的组合物、设备以及方法
WO2017195871A1 (ja) * 2016-05-13 2017-11-16 応用酵素医学研究所株式会社 アレルギー発症リスクを予測するためのデータを収集する方法
RU2621312C1 (ru) * 2016-06-15 2017-06-01 Федеральное государственное автономное учреждение "Научный центр здоровья детей" Министерства здравоохранения Российской Федерации (ФГАУ "НЦЗД" Минздрава России) Способ прогнозирования формирования толерантности при аллергии к белку коровьего молока у детей раннего возраста
KR102327467B1 (ko) * 2016-06-16 2021-11-16 호유 가부시키가이샤 생선 알레르기의 항원
CN110716055A (zh) * 2019-09-11 2020-01-21 天津医科大学 过敏原特异性免疫球蛋白e致病活性检测试剂盒
WO2022050416A1 (ja) * 2020-09-07 2022-03-10 三菱瓦斯化学株式会社 アレルギー疾患の判定方法及び判定システム
JP7555788B2 (ja) 2020-10-30 2024-09-25 アサヒグループホールディングス株式会社 タンパク質の起源種判別方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736362A (en) * 1990-10-26 1998-04-07 The University Of Melbourne Ryegrass pollen allergen
US5567594A (en) * 1991-04-26 1996-10-22 Enteron, L.P. Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms
US5480972A (en) * 1992-10-30 1996-01-02 The University Of Melbourne Allergenic proteins from Johnson grass pollen
US5558869A (en) * 1992-12-30 1996-09-24 University Of Arkansas Major peanut allergen ara h II
WO1994016068A2 (en) * 1992-12-31 1994-07-21 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from dog dander and uses therefor

Also Published As

Publication number Publication date
ES2383002T3 (es) 2012-06-15
EP1051626A1 (de) 2000-11-15
JP4292262B2 (ja) 2009-07-08
WO1999039211A1 (en) 1999-08-05
JP2002502039A (ja) 2002-01-22
AU741635B2 (en) 2001-12-06
AU2347899A (en) 1999-08-16
US6238925B1 (en) 2001-05-29
EP1939628A1 (de) 2008-07-02
EP1939628B1 (de) 2012-03-21
ES2229673T3 (es) 2009-08-04
CA2319317A1 (en) 1999-08-05
HK1120865A1 (en) 2009-04-09
EP1051626B1 (de) 2009-03-18
CA2319317C (en) 2006-04-18
HK1032262A1 (en) 2001-07-13
DE69919327D1 (de) 2009-11-26
DE69919327T2 (de) 2005-03-10
ATE550665T1 (de) 2012-04-15

Similar Documents

Publication Publication Date Title
HK1120865A1 (en) Prognostic allergy test
RU2004136285A (ru) Способ диагностики гепатоцеллюлярной карциномы
Churchman et al. Multiplexing immunoassays for cytokine detection in the serum of patients with rheumatoid arthritis: lack of sensitivity and interference by rheumatoid factor
HK1223947A1 (zh) 用於檢測 -末端 的多克隆-單克隆 方法
ATE126594T1 (de) Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen.
ATE245169T1 (de) Monoklonale antikörper spezifisch für endprodukte der fortgeschrittenen glycosylation in biologischen proben
DK0378175T3 (da) Diagnostisk påvisning under anvendelse af kimære antistoffer
KR20120004990A (ko) 관절염 상태를 특성화하는 조성물 및 방법
DE602005025559D1 (de) Diagnostischer Test für menschliches matrix Gla-Protein und seine Verwendung als Biomarker
DE50210021D1 (de) Antikörper zum spezifischen Nachweis von pathogenen Prionen humanen Ursprungs und damit durchgeführte Nachweisverfahren
ATE121788T1 (de) Blutgerinnungsfaktor beta xiia monoklonale antikörper und immunanalyse.
DE69112225D1 (de) Immunodiagnostische probe für gelenkrheumatismus.
Ohnishi et al. Development of highly sensitive enzyme-linked immunosorbent assays for hepatocyte growth factor/scatter factor (HGF/SF): determination of HGF/SF in serum and urine from normal human subjects
JPH10507266A (ja) 体液中のコラーゲンの断片化パターンの評価とコラーゲンの代謝に関連する疾患の診断
DE60037115D1 (de) Diagnostischer test für menschlisches matrix gla-protein und seine verwendung als biomarker
DK0747481T3 (da) Epstein-Barr-viruspeptider og antistoffer mod disse peptider
DK0526397T3 (da) Immunologisk påvisningsfremgangsmåde
NO913037L (no) Peptider med for alfal-mikroglobulin karakteristiske antigene determinanter.
Phillips et al. Quantitative characterization of specificity and potency of conjugated antibody with solid-phase, antigen bead standards
DE69522021D1 (de) Monoklonaler Antikörper und seine Verwendung in einem Immunoassay
KR870002453A (ko) 프로좀 단백질에 대한 단일항체의 제조방법 및 그를 이용한 프로좀과 관련된 현상의 검출 및 질병의 진단법
Hamilton Molecular engineering: applications to the clinical laboratory
ATE249043T1 (de) Immunoassay und kit für iga antikörper, spezifisch für acetaldehyd-addukte
ATE389175T1 (de) Verfahren zur prüfung von antigenen, die mit durch mentalen stress bedingten erkrankungen assoziiert sind
Sheng et al. Electroimmunoblotting of myelin basic protein peptides: a novel approach to the rapid characterisation of antigenic specificities of monoclonal and polyclonal anti-MBP antibodies

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties